DPIIT recognised startup Government of India
Startup India
Spensus Pharmaceuticals Private Limited - pharma in Kadi, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹5.59 Cr
▲ 48995% YoY
Net loss · FY 2024
₹1.49 Cr
Net margin -26.7%
EBITDA · FY 2024
₹1.13 Cr
EBITDA margin 20.2%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹5.2 Cr
Issued & subscribed
Open charges
₹17.98 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Employees · EPFO
4
Provident fund records
About Spensus Pharmaceuticals Private Limited
Data last updated:
Spensus Pharmaceuticals Private Limited is a private limited company based in Kadi, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2018PTC100978. Its GSTIN is 24AAZCS8921N1ZC (Gujarat).
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.2 Cr. It is led by directors Nileshkumar Haribhai Patel and Tanmay Natvarbhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Kadi, Gujarat.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.59 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.49 Cr (net margin -26.7%) and EBITDA of ₹1.13 Cr (EBITDA margin 20.2%).
The company has about 4 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: SPENSUS Pharma and Ambix Healthcare LLP. As per MCA filings, the company has open charges of ₹17.98 Cr on record.
Spensus Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-14-0007061). For more details, the company can be reached via its website spensuspharma.com.
Company details
CIN U74999GJ2018PTC100978
Registration Number 100978
Incorporation Date 24 February 2018
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-GJ-14-0007061
Recognitions & Rankings of Spensus Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-14-0007061
Contact details
Spensus Pharmaceuticals Private Limited's registered office is in Kadi, Gujarat. Its website is spensuspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressUnit No.1 Survey No.284 B/H Honest Hotel Dhanali Road Ahmedabad – Mehsana Highway G, Aneshpura, Kadi, Gujarat, India – 382705
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Spensus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Spensus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Spensus Pharmaceuticals operates two associated brands: SPENSUS Pharma and Ambix Healthcare LLP. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops, manufactures, and markets pharmaceutical formulations worldwide. | spensuspharma.com | |
| Indian company developing, manufacturing, and exporting pharmaceutical products globally. | ambixhealthcare.com |
Business activity
The main business activity of Spensus Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Spensus Pharmaceuticals Private Limited, buy the company report.
Financials of Spensus Pharmaceuticals Private Limited
FY 2024 filings availableSpensus Pharmaceuticals Private Limited reported revenue of ₹5.59 Cr (up 48995% YoY) for FY 2024.
Revenue · FY 2024
₹5.59 Cr ▲ 48995%
Net loss · FY 2024
₹1.49 Cr margin -26.7%
EBITDA · FY 2024
₹1.13 Cr margin 20.2%
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹5.59 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.49 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.2% | ||||
| Net Profit Margin | -26.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spensus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Spensus Pharmaceuticals Private Limited
Spensus Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nileshkumar Haribhai Patel Also directs: Uma Metaldec Private Limited | Director | 24 Feb 2018 | 8 Years 8 Months | Current |
| Tanmay Natvarbhai Patel Also directs: Carecroft Pharma Distributions LLP, Carecroft Pharmacy LLP, Carecroft Naranpura LLP and 1 more | Director | 24 Feb 2018 | 8 Years 8 Months | Current |
Auditor
Spensus Pharmaceuticals Private Limited is audited by MUKESH P. PATEL & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUKESH P. PATEL & CO. | FY 2024 | 106629W |
Shareholding
The shareholding of Spensus Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Spensus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹17.98 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Aug 2024 | 100973252 | Sidbi | ₹3.48 Cr | Open | |
| 13 Jan 2022 | 100532879 | Sidbi | ₹9 Cr | Open | |
| 13 Jan 2022 | 100533938 | Sidbi | ₹5 Cr | Open | |
| 13 Jan 2022 | 100532868 | Sidbi | ₹50 Lakh | Open |
To see the full charge records of Spensus Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Spensus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spensus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Spensus Pharmaceuticals Private Limited has a workforce of 4 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
4
Active EPFO establishments
1
Employee growth
-20%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 4 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Spensus Pharmaceuticals Private Limited, buy the company report.
GST
Spensus Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAZCS8921N1ZC | Gujarat | Active | 21 Apr 2018 |
To see the full GST registrations and return filing status of Spensus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Spensus Pharmaceuticals Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Harilal Bhagvandas Patel ceased to be Director on 07 Sep 2020.
AGM
Spensus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Sidbi amounted to Rs. 3.48 Cr with Charge ID 100973252 was registered on 27 Aug 2024.
Charges
A charge with Sidbi of Rs. 5.00 Cr registered on 13 Jan 2022 with Charge ID 100533938 was modified on 27 Aug 2024.
Filing
Spensus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge with Sidbi of Rs. 9.00 Cr registered on 13 Jan 2022 with Charge ID 100532879 was modified on 22 Feb 2022.
Charges
A charge with Sidbi of Rs. 0.50 Cr registered on 13 Jan 2022 with Charge ID 100532868 was modified on 22 Feb 2022.
Charges
A charge with Sidbi amounted to Rs. 9.00 Cr with Charge ID 100532879 was registered on 13 Jan 2022.
Charges
A charge with Sidbi amounted to Rs. 0.50 Cr with Charge ID 100532868 was registered on 13 Jan 2022.
Charges
A charge with Sidbi amounted to Rs. 5.00 Cr with Charge ID 100533938 was registered on 13 Jan 2022.
Ceased
Harilal Bhagvandas Patel ceased to be Director.
Ceased
Kinjalben Nileshkumar Patel ceased to be Director.
Ceased
Natvarlal Vitthalbhai Patel ceased to be Director.
3 earlier events are in the company report.
Frequently asked questions
Spensus Pharmaceuticals is an active private limited company based in Kadi, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 February 2018 (8+ years old) and is registered under CIN U74999GJ2018PTC100978.
Spensus Pharmaceuticals has 2 current directors:
- Nileshkumar Haribhai Patel - Director
- Tanmay Natvarbhai Patel - Director
The latest financial statements of Spensus Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Spensus Pharmaceuticals is 24AAZCS8921N1ZC, registered in Gujarat.
The CIN (Corporate Identification Number) of Spensus Pharmaceuticals is U74999GJ2018PTC100978. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spensus Pharmaceuticals was incorporated on 24 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Harilal Bhagvandas Patel ceased to be Director on 07 Sep 2020. Kinjalben Nileshkumar Patel ceased to be Director on 07 Sep 2020. Natvarlal Vitthalbhai Patel ceased to be Director on 07 Sep 2020. Spensus Pharmaceuticals has 5 board changes on record in total.
Yes, Spensus Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Spensus Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-14-0007061).
Spensus Pharmaceuticals can be reached through the website spensuspharma.com. Its registered office is in Kadi, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages